Neuropsychological features of diffuse Lewy body disease

被引:6
|
作者
Wagner, MT
Bachman, DL
机构
[1] Dept. of Psychiat. and Behav. Sci., Annex 1, Medical University of South Carolina, Charleston, SC 29425
关键词
D O I
10.1016/0887-6177(95)00022-4
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
A case of a 60-year-old man with biopsy-proven diffuse Lewy body disease was presented with clinical and serial neuropsychological data. Findings showed a rapid decline over a 2-year period characterized by an atypical degenerative dementia, including a global mental decline with presented orientation, profound perceptual deficits, and no specific relative progressive memory impairment. Few extrapyramidal signs were noted, but subtle visual hallucinations and vivid nightmares occurred throughout the course. He underwent an experimental trial of tacrine, but showed an adverse reaction. Of the few detailed neurocognitive case descriptions of this disease found in the literature, this article highlights the unique variability and clinical manifestations that differentiate this disorder from the dementia of the Alzheimer's type.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 50 条
  • [31] NEUROPSYCHIATRIC MANIFESTATIONS OF DIFFUSE LEWY BODY DISEASE
    BECK, BJ
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 1995, 8 (03) : 189 - 196
  • [32] ANTEMORTEM DIAGNOSIS OF DIFFUSE LEWY BODY DISEASE
    CRYSTAL, HA
    DICKSON, DW
    LIZARDI, JE
    DAVIES, P
    WOLFSON, LI
    NEUROLOGY, 1990, 40 (10) : 1523 - 1528
  • [33] AMYLOID ANGIOPATHY IN DIFFUSE LEWY BODY DISEASE
    WU, E
    DICKSON, DW
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1990, 49 (03): : 276 - 276
  • [34] Autosomal dominant diffuse Lewy body disease
    Wakabayashi, K
    Hayashi, S
    Ishikawa, A
    Hayashi, T
    Okuizumi, K
    Tanaka, H
    Tsuji, S
    Takahashi, H
    ACTA NEUROPATHOLOGICA, 1998, 96 (02) : 207 - 210
  • [35] Clinicopathological studies on diffuse Lewy body disease
    Kosaka, K
    Iseki, E
    NEUROPATHOLOGY, 2000, 20 (01) : 1 - 7
  • [36] Glial involvement in diffuse Lewy body disease
    Terada, S
    Ishizu, H
    Yokota, O
    Tsuchiya, K
    Nakashima, H
    Ishihara, T
    Fujita, D
    Uéda, K
    Ikeda, K
    Kuroda, S
    ACTA NEUROPATHOLOGICA, 2003, 105 (02) : 163 - 169
  • [37] Glucocerebrosidase mutations in diffuse Lewy body disease
    Nishioka, Kenya
    Ross, Owen A.
    Vilarino-Gueell, Carles
    Cobb, Stephanie A.
    Kachergus, Jennifer M.
    Mann, David M. A.
    Snowden, Julie
    Richardson, Anna M. T.
    Neary, David
    Robinson, Christopher A.
    Rajput, Alex
    Papapetropoulos, Spiridon
    Mash, Deborah C.
    Pahwa, Rajesh
    Lyons, Kelly E.
    Wszolek, Zbigniew K.
    Dickson, Dennis W.
    Farrer, Matthew J.
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (01) : 55 - 57
  • [38] CLOZAPINE USE IN DIFFUSE LEWY BODY DISEASE
    CHACKO, RC
    HURLEY, RA
    JANKOVIC, J
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1993, 5 (02) : 206 - 208
  • [39] Association of α-, β-, and γ-Synuclein With Diffuse Lewy Body Disease
    Nishioka, Kenya
    Wider, Christian
    Vilarino-Gueell, Carles
    Soto-Ortolaza, Alexandra I.
    Lincoln, Sarah J.
    Kachergus, Jennifer M.
    Jasinska-Myga, Barbara
    Ross, Owen A.
    Rajput, Alex
    Robinson, Christopher A.
    Ferman, Tanis J.
    Wszolek, Zbigniew K.
    Dickson, Dennis W.
    Farrer, Matthew J.
    ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 970 - 975
  • [40] Autosomal dominant diffuse Lewy body disease
    K. Wakabayashi
    Shintaro Hayashi
    Atsushi Ishikawa
    Tunemi Hayashi
    Kaoru Okuizumi
    Hajime Tanaka
    Shoji Tsuji
    Hitoshi Takahashi
    Acta Neuropathologica, 1998, 96 : 207 - 210